Molecular BiologybioRxivPreprint
Chimeric chikungunya virus-like particles with surface exposed SARS-CoV-2 RBD elicits potent immunogenic responses in mice.
Vedita Anand Singh, Sanketkumar Nehul, Chandra Shekhar Kumar…·Shailly Tomar
This study develops a bivalent chimeric virus-like particle vaccine displaying CHIKV and SARS-CoV-2 RBD antigens, showing potent immunogenicity in mice.
3 citations